Overview
- 121 inspections across 118 sites are on record.
- 212 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
121
Sites
118
Observations
212
Career since
Apr 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Devi Pharmatech Private Limited | 24 Apr 2026 | Human Drugs | |
| SR Generics Private Limited | 17 Apr 2026 | Human Drugs | |
| INDOCO REMEDIES LIMITED | 10 Apr 2026 | Human Drugs | |
| ONY Biotech, Inc. | 5 Feb 2026 | Human Drugs | On file |
| Guardian Drug Co. Inc. | 16 Jan 2026 | Human Drugs |
Sites inspected
Devi Pharmatech Private LimitedVisakhapatnam, India1 insp.
SR Generics Private LimitedPinamadaka, India1 insp.
INDOCO REMEDIES LIMITEDAurangabad (Chhatrapati Sambhajinagar), India1 insp.
ONY Biotech, Inc.Amherst, United States1 insp.
Guardian Drug Co. Inc.Dayton, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tanya R Syffrard5 shared
Mindy M Chou3 shared
Bijoy Panicker3 shared
Djamila Harouaka3 shared
Alisha B Patel2 shared
Cynthia Jim2 shared
Vivin George2 shared
Patric C Klotzbuecher2 shared
Taichun Qin2 shared
Anastasia M Shields2 shared
Full investigator report
Get the verbatim findings behind Gam S Zamil's 212 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site